ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836,392 | +6.5% | 8,932 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $785,400 | +46.5% | 8,800 | +76.0% | 0.00% | 0.0% |
| Q1 2023 | $536,100 | +58.0% | 5,000 | +79.9% | 0.00% | – |
| Q4 2022 | $339,399 | -51.0% | 2,779 | -52.9% | 0.00% | -100.0% |
| Q1 2022 | $692,000 | +207.6% | 5,900 | +318.4% | 0.00% | – |
| Q3 2021 | $225,000 | -60.4% | 1,410 | -67.3% | 0.00% | – |
| Q2 2021 | $568,000 | +2.2% | 4,314 | +0.0% | 0.00% | – |
| Q1 2021 | $556,000 | -22.7% | 4,313 | +0.1% | 0.00% | – |
| Q4 2020 | $719,000 | +5.7% | 4,310 | -2.0% | 0.00% | – |
| Q3 2020 | $680,000 | -42.5% | 4,399 | -44.9% | 0.00% | -100.0% |
| Q2 2020 | $1,182,000 | +52.7% | 7,990 | +16.3% | 0.00% | 0.0% |
| Q1 2020 | $774,000 | -64.1% | 6,869 | -55.7% | 0.00% | -50.0% |
| Q4 2019 | $2,156,000 | +436.3% | 15,504 | +271.2% | 0.00% | – |
| Q3 2019 | $402,000 | +33.1% | 4,177 | -72.2% | 0.00% | – |
| Q3 2016 | $302,000 | +42.5% | 15,031 | -6.2% | 0.00% | – |
| Q2 2016 | $212,000 | +14.0% | 16,030 | +60.0% | 0.00% | – |
| Q1 2016 | $186,000 | -9.3% | 10,016 | -10.7% | 0.00% | – |
| Q4 2015 | $205,000 | – | 11,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |